Are you Dr. Elvin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 Corporate Pl
Suite 7
Peabody, MA 01960Phone+1 978-535-3317Fax+1 978-535-2371
Summary
- Dr. Julia Elvin, MD is a board certified pathologist in Peabody, Massachusetts. She is currently licensed to practice medicine in Massachusetts, New Hampshire, and Connecticut.
Education & Training
- Brigham and Womens HospitalFellowship, Selective Pathology, 2004 - 2005
- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2002 - 2004
- Baylor College of MedicineInternship, Transitional Year, 2001 - 2002
- Baylor College of MedicineClass of 2001
Certifications & Licensure
- NH State Medical License 2014 - Present
- VT State Medical License Current
- MA State Medical License 2005 - 2025
- CT State Medical License 2013 - 2014
- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- Durable partial response to pembrolizumab, lenvatinib, and letrozole in a case of recurrent uterine carcinosarcoma withgene amplification.Jenny L Soiffer, Alexander J Fife, Shrikanth S Gadad, Javier A Laurini, Julia A Elvin
Gynecologic Oncology Reports. 2024-08-01 - Targetable ERBB2/HER2 Mutations in Gynecologic Malignancies: Clinicopathological, Immunohistochemical, and Molecular Correlations.Padmini A Manrai, Austin McHenry, Tong Sun, Alessandro D Santin, Elena Ratner
International Journal of Gynecological Pathology. 2024-06-10 - 1 citationsLiquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.Douglas A Mata, Jessica K Lee, Vignesh Shanmugam, Chelsea B Marcus, Alexa B Schrock
Histopathology. 2024-06-01
Press Mentions
- Comprehensive Genomic Profiling May Identify Select Subsets in Ovarian CancerAugust 11th, 2017